ACADIA Pharmaceuticals Inc.
ACAD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $320 | $189 | $115 | $147 |
| Short-Term Investments | $436 | $250 | $302 | $373 |
| Receivables | $105 | $102 | $63 | $65 |
| Inventory | $22 | $36 | $7 | $8 |
| Other Curr. Assets | $56 | $39 | $21 | $24 |
| Total Curr. Assets | $938 | $616 | $508 | $618 |
| Property Plant & Equip (Net) | $51 | $56 | $62 | $66 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $120 | $65 | $0 | $0 |
| Long-Term Investments | $0 | $6 | $13 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $79 | $5 | $5 | $16 |
| Total NC Assets | $249 | $133 | $80 | $82 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,188 | $749 | $588 | $700 |
| Liabilities | – | – | – | – |
| Payables | $16 | $18 | $13 | $7 |
| Short-Term Debt | $10 | $9 | $9 | $8 |
| Tax Payable | $12 | $2 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $357 | $226 | $103 | $81 |
| Total Curr. Liab. | $395 | $254 | $126 | $96 |
| LT Debt | $42 | $48 | $53 | $56 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $18 | $15 | $9 | $7 |
| Total NC Liab. | $60 | $63 | $62 | $63 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $52 | $48 | $62 | $64 |
| Total Liabilities | $455 | $317 | $187 | $159 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$2,204 | -$2,431 | -$2,370 | -$2,154 |
| AOCI | $0 | $0 | -$1 | -$0 |
| Other Equity | $2,937 | $2,863 | $2,771 | $2,695 |
| Total Equity | $733 | $432 | $400 | $541 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,188 | $749 | $588 | $700 |
| Net Debt | -$268 | -$131 | -$53 | -$83 |